<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03060000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P18089</UniProt_ID>
  <Seq_Length>450</Seq_Length>
  <Molecule_Weight>49954</Molecule_Weight>
  <KEGG_ID>hsa:151</KEGG_ID>
  <Orthology_ID>K04139</Orthology_ID>
  <Function_Summary>Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is clonidine </Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Alpha-2B adrenoreceptor</Alias>
      <Alias>Alpha-2-adrenergic receptor-like 1</Alias>
      <Alias>Alpha-2 adrenergic receptor subtype C2</Alias>
      <Alias>Alpha-2BAR</Alias>
      <Alias>Adrenergic receptor alpha 2B</Alias>
      <Alias>ADRA2B adrenergic, alpha-2B-, receptor</Alias>
      <Alias>Alpha-2B-adrenergic receptor</Alias>
      <Alias>Alpha-2B adrenoceptor</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with epinephrine, a hormone produced by the medulla of the adrenal glands that increases heart activity, improves the power and prolongs the action of muscles, and increases the rate and depth of breathing. It is synthesized by the methylation of norepinephrine.</Detail>
      <Keyword>Epinephrine binding</Keyword>
      <Ontology_ID>GO:0051379</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of alpha2-adrenergic receptors; the activity involves transmitting the signal to the Gi alpha subunit of a heterotrimeric G protein.</Detail>
      <Keyword>Alpha2-adrenergic receptor activity</Keyword>
      <Ontology_ID>GO:0004938</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>211</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>376</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>379</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>379</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that mediates the transfer of information from one cell to another.</Detail>
      <Keyword>Cell-cell signaling</Keyword>
      <Ontology_ID>GO:0007267</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of epinephrine.</Detail>
      <Keyword>Negative regulation of epinephrine secretion</Keyword>
      <Ontology_ID>GO:0032811</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, followed by the activation of a MAP kinase.</Detail>
      <Keyword>Activation of MAPK activity by adrenergic receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0071883</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the frequency, rate or extent of the regulated release of norepinephrine.</Detail>
      <Keyword>Negative regulation of norepinephrine secretion</Keyword>
      <Ontology_ID>GO:0010700</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.</Detail>
      <Keyword>Platelet activation</Keyword>
      <Ontology_ID>GO:0030168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of neuron differentiation.</Detail>
      <Keyword>Positive regulation of neuron differentiation</Keyword>
      <Ontology_ID>GO:0045666</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which an epidermal growth factor receptor is activated via signaling events from a G-protein coupled receptor. This is an example of cross-talk between the EGFR and GPCR signaling pathways.</Detail>
      <Keyword>Epidermal growth factor receptor transactivation by G-protein coupled receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0035625</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that initiates the activity of the inactive enzyme protein kinase B.</Detail>
      <Keyword>Activation of protein kinase B activity</Keyword>
      <Ontology_ID>GO:0032148</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MDHQDPYSVQATAAIAAAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADILVATLIIPFSLANELLGYWYFRRTWCEVYLALDVLFCTSSIVHLCAISLDRYWAVSRALEYNSKRTPRRIKCIILTVWLIAAVISLPPLIYKGDQGPQPRGRPQCKLNQEAWYILASSIGSFFAPCLIMILVYLRIYLIAKRSNRRGPRAKGGPGQGESKQPRPDHGGALASAKLPALASVASAREVNGHSKSTGEKEEGETPEDTGTRALPPSWAALPNSGQGQKEGVCGASPEDEAEEEEEEEEEEEECEPQAVPVSPASACSPPLQQPQGSRVLATLRGQVLLGRGVGAIGGQWWRRRAQLTREKRFTFVLAVVIGVFVLCWFPFFFSYSLGAICPKHCKVPHGLFQFFFWIGYCNSSLNPVIYTIFNQDFRRAFRRILCRPWTQTAW</Protein_Seq>
    <DNA_Seq>CTGCAGGCGCGGCTGGGGCGAAACGTGCGAGCTGAGCGGGCGCAAGGTCCTCCGCGCCTCCTTTAAGAACCGGCCCAGCCCGGCCCGCGCCCCCAGAGCGTACGGCATCCGCGTGGCGGAGGGCGCGACTTTCTCCGGTCCCGGGCGGGACGGGGACGGCGGCGGGACAACTTGGGAAACTTCTCTGGGGCGGACGGCAGGGACCCCGGGCACCGTGGAGGAGGATGTAGGAGGGCGGCTGCTGGTCCTGGGTGTTCCCGACCTCCTAGGCCCCGCTCGTCCAGGCCATGGGGCTCCAGCGCCCTCGCGGCGCCGGAGGGGCGACGCTCTTGTCTAGCCGAGCCGGGCAGCGCTGTCGTCCACGGTGCGCACTGGGCGGGCAGCGCTCCCTCTGCCCACCTCCCGCCCCGTCATGGACCACCAGGACCCCTACTCCGTGCAGGCCACAGCGGCCATAGCGGCGGCCATCACCTTCCTCATTCTCTTTACCATCTTCGGCAACGCTCTGGTCATCCTGGCTGTGTTGACCAGCCGCTCGCTGCGCGCCCCTCAGAACCTGTTCCTGGTGTCGCTGGCCGCCGCCGACATCCTGGTGGCCACGCTCATCATCCCTTTCTCGCTGGCCAACGAGCTGCTGGGCTACTGGTACTTCCGGCGCACGTGGTGCGAGGTGTACCTGGCGCTCGACGTGCTCTTCTGCACCTCGTCCATCGTGCACCTGTGCGCCATCAGCCTGGACCGCTACTGGGCCGTGAGCCGCGCGCTGGAGTACAACTCCAAGCGCACCCCGCGCCGCATCAAGTGCATCATCCTCACTGTGTGGCTCATCGCCGCCGTCATCTCGCTGCCGCCCCTCATCTACAAGGGCGACCAGGGCCCCCAGCCGCGCGGGCGCCCCCAGTGCAAGCTCAACCAGGAGGCCTGGTACATCCTGGCCTCCAGCATCGGATCTTTCTTTGCTCCTTGCCTCATCATGATCCTTGTCTACCTGCGCATCTACCTGATCGCCAAACGCAGCAACCGCAGAGGTCCCAGGGCCAAGGGGGGGCCTGGGCAGGGTGAGTCCAAGCAGCCCCGACCCGACCATGGTGGGGCTTTGGCCTCAGCCAAACTGCCAGCCCTGGCCTCTGTGGCTTCTGCCAGAGAGGTCAACGGACACTCGAAGTCCACTGGGGAGAAGGAGGAGGGGGAGACCCCTGAAGATACTGGGACCCGGGCCTTGCCACCCAGTTGGGCTGCCCTTCCCAACTCAGGCCAGGGCCAGAAGGAGGGTGTTTGTGGGGCATCTCCAGAGGATGAAGCTGAAGAGGAGGAAGAGGAGGAGGAGGAGGAGGAAGAGTGTGAACCCCAGGCAGTGCCAGTGTCTCCGGCCTCAGCTTGCAGCCCCCCGCTGCAGCAGCCACAGGGCTCCCGGGTGCTGGCCACCCTACGTGGCCAGGTGCTCCTGGGCAGGGGCGTGGGTGCTATAGGTGGGCAGTGGTGGCGTCGAAGGGCGCACGTGACCCGGGAGAAGCGCTTCACCTTCGTGCTGGCTGTGGTCATTGGCGTTTTTGTGCTCTGCTGGTTCCCCTTCTTCTTCAGCTACAGCCTGGGCGCCATCTGCCCGAAGCACTGCAAGGTGCCCCATGGCCTCTTCCAGTTCTTCTTCTGGATCGGCTACTGCAACAGCTCACTGAACCCTGTTATCTACACCATCTTCAACCAGGACTTCCGCCGTGCCTTCCGGAGGATCCTGTGCCGCCCGTGGACCCAGACGGCCTGGTGAGCCCGCCTGCGCTGCCCCTGTGGGTTGGTGCGGTGGCGCCGGGGTCACCCTGCTTCTTGCCCTGCTGTGTGTGGCTGCCTCCCCTGGGCTTTCTGCTCCCTGCCCAGATCCTGTAGGCCTCATCTTAGGAACCCCTTGGGAGGGGTGGGCAGGGGGGCTGCTAGCAAGGGTCCCAGTGAAGCTTCCCCTTGCCGGCTTAGCTGTGGGGGACCCCTTCTCCACCCTCTCCCTGAGCACAGGCCGATGGAGGTGGTTCAAATCCTCTGGAACATAGCCAAGACCAGGAGAAGAGAGAGCACTTTCTTCC</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ADRA2B</Gene_Name>
    <Gene_Alias>ADRA2L1; ADRA2RL1</Gene_Alias>
    <Gene_ID>151</Gene_ID>
    <Genbank_ACCN>NM_000682</Genbank_ACCN>
    <Protein_ACCN>NP_000673</Protein_ACCN>
    <HGNC_ID>282</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/151</Gene_URL>
    <UCSC_ID>uc021vlh.1</UCSC_ID>
    <EMBL_ID>ENSG00000222040</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Obesity</Disease_Name>
      <Disease_Detail>Obesity</Disease_Detail>
      <Disease_DB>OBS005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/obesity?search=ADRA2B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Coronary Restenosis</Disease_Name>
      <Disease_Detail>Coronary Restenosis</Disease_Detail>
      <Disease_DB>CRN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/coronary_restenosis?search=ADRA2B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Morbid Obesity</Disease_Name>
      <Disease_Detail>Morbid Obesity</Disease_Detail>
      <Disease_DB>MRB003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/morbid_obesity?search=ADRA2B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epilepsy, Familial Adult Myoclonic, 5</Disease_Name>
      <Disease_Detail>Epilepsy</Disease_Detail>
      <Disease_DB>EPL103</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epilepsy_familial_adult_myoclonic_5?search=ADRA2B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Orthostatic Intolerance</Disease_Name>
      <Disease_Detail>Orthostatic Intolerance</Disease_Detail>
      <Disease_DB>ORT004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/orthostatic_intolerance?search=ADRA2B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Neurologic Diseases</Disease_Name>
      <Disease_Detail>Neurologic Diseases</Disease_Detail>
      <Disease_DB>NRL007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/neurologic_diseases?search=ADRA2B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Essential Hypertension</Disease_Name>
      <Disease_Detail>Essential Hypertension</Disease_Detail>
      <Disease_DB>ESS002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/essential_hypertension?search=ADRA2B#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Type 2 Diabetes Mellitus</Disease_Name>
      <Disease_Detail>Diabetes Mellitus</Disease_Detail>
      <Disease_DB>TYP009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/type_2_diabetes_mellitus?search=ADRA2B#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of alpha-2B adrenergic receptor</PDB_Title>
      <PDB_ID>ASD03060000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
  </PDB_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00170297</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>